Literature DB >> 17047982

The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome.

Susanne Ring-Dimitriou1, Bernhard Paulweber, Serge P von Duvillard, Monika Stadlmann, Linda M LeMura, Josef Lang, Erich Müller.   

Abstract

The purpose of this study was to measure changes in plasma adiponectin (ApN) over 24 months of exercise intervention in middle age adults with a predisposition to metabolic syndrome and to determine if changes in ApN were more affected by physical activity or physical fitness. Thirty-six subjects completed a 24 months home-based exercise program (cycling>or=three times per week, >or=45 min/session at 50-65% of VO2peak). Body composition, blood samples, and physical fitness were studied at baseline and after 12 and 24 months of participation in the study. The prescribed physical activity was monitored via self-reported exercise diary to determine MET levels, hours, and exercise compliance. Two-tailed repeated measures ANOVA and Spearman Rank Correlation Coefficients were used to detect significant differences and associations between the variables. ApN increased significantly (P<0.05) after 12 months in males (n=17; 5.3+/-1.9-7.0+/-3.0 microg ml-1) but not in females (n=9; 8.6+/-3.8-11.5+/-4.0 microg ml-1). The net change in ApN over 24 months was significantly correlated to the net change in VO2peak (physical fitness) (r=0.66; P<0.001), whereas exercise intensity was negatively correlated to DeltaApN over 12 months (r=-0.4; P<or=0.04) and 24 months (r=-0.45; P<or=0.02). Based on our results, an improvement in cardiorespiratory fitness of 15% increased plasma ApN concentration. Our findings suggest that moderate physical activity performed over many months induces positive changes in the plasma ApN concentration in adults with a predisposition to metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047982     DOI: 10.1007/s00421-006-0291-9

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.346


  35 in total

1.  Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.

Authors:  A Katsuki; Y Sumida; E C Gabazza; S Murashima; M Furuta; R Araki-Sasaki; Y Hori; Y Yano; Y Adachi
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

2.  Exercise training is not associated with improved levels of C-reactive protein or adiponectin.

Authors:  Taylor J Marcell; Kirsten A McAuley; Tinna Traustadóttir; Peter D Reaven
Journal:  Metabolism       Date:  2005-04       Impact factor: 8.694

3.  Lower-body fat mass as an independent marker of insulin sensitivity--the role of adiponectin.

Authors:  B Buemann; T I A Sørensen; O Pedersen; E Black; C Holst; S Toubro; S Echwald; J J Holst; C Rasmussen; A Astrup
Journal:  Int J Obes (Lond)       Date:  2005-06       Impact factor: 5.095

4.  Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men.

Authors:  Lu Qi; Eric Rimm; Simin Liu; Nader Rifai; Frank B Hu
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

5.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Plasma adiponectin levels and risk of myocardial infarction in men.

Authors:  Tobias Pischon; Cynthia J Girman; Gokhan S Hotamisligil; Nader Rifai; Frank B Hu; Eric B Rimm
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

7.  The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle.

Authors:  Chamindie Punyadeera; Antoine H G Zorenc; René Koopman; Andrew J McAinch; Egbert Smit; Ralph Manders; Hans A Keizer; David Cameron-Smith; Luc J C van Loon
Journal:  Eur J Endocrinol       Date:  2005-03       Impact factor: 6.664

8.  Waist circumference as a measure for indicating need for weight management.

Authors:  M E Lean; T S Han; C E Morrison
Journal:  BMJ       Date:  1995-07-15

9.  Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men.

Authors:  P Boudou; E Sobngwi; F Mauvais-Jarvis; P Vexiau; J-F Gautier
Journal:  Eur J Endocrinol       Date:  2003-11       Impact factor: 6.664

10.  Association between lifestyle factors and plasma adiponectin levels in Japanese men.

Authors:  Rumi Tsukinoki; Kanehisa Morimoto; Kunio Nakayama
Journal:  Lipids Health Dis       Date:  2005-11-02       Impact factor: 3.876

View more
  11 in total

1.  Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults.

Authors:  Ji-Young Lee; Jin-Kyung Cho; Hye-Ryun Hong; Young-Yoon Jin; Hyun-Sik Kang
Journal:  Eur J Appl Physiol       Date:  2011-06-01       Impact factor: 3.078

2.  Time spent in sedentary posture is associated with waist circumference and cardiovascular risk.

Authors:  W W Tigbe; M H Granat; N Sattar; M E J Lean
Journal:  Int J Obes (Lond)       Date:  2017-01-31       Impact factor: 5.095

3.  Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat.

Authors:  Joseph M Company; Frank W Booth; M Harold Laughlin; Arturo A Arce-Esquivel; Harold S Sacks; Suleiman W Bahouth; John N Fain
Journal:  J Appl Physiol (1985)       Date:  2010-10-14

4.  Exercise-induced Signals for Vascular Endothelial Adaptations: Implications for Cardiovascular Disease.

Authors:  Nathan T Jenkins; Jeffrey S Martin; M Harold Laughlin; Jaume Padilla
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-08-01

5.  A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes.

Authors:  L Maria Belalcazar; George D Papandonatos; Jeanne M McCaffery; Inga Peter; Nicholas M Pajewski; Bahar Erar; Nicholette D Allred; Ashok Balasubramanyam; Donald W Bowden; Ariel Brautbar; F Xavier Pi-Sunyer; Christie M Ballantyne; Gordon S Huggins
Journal:  Physiol Genomics       Date:  2015-03-10       Impact factor: 3.107

Review 6.  Effects of exercise on adipokines and the metabolic syndrome.

Authors:  Tongjian You; Barbara J Nicklas
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  Circulating adiponectin levels are associated with peak oxygen uptake in Japanese.

Authors:  Nobuyuki Miyatake; Takeyuki Numata; Haruka Murakami; Ryoko Kawakami; Kiyoshi Sanada; Izumi Tabata; Motohiko Miyachi
Journal:  Environ Health Prev Med       Date:  2014-04-06       Impact factor: 3.674

8.  Changes of Serum Adiponectin and Testosterone Concentrations Following Twelve Weeks Resistance Training in Obese Young Men.

Authors:  Fatah Moradi
Journal:  Asian J Sports Med       Date:  2015-12-01

9.  Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function.

Authors:  Vanja Ivković; Mislav Jelaković; Mario Laganović; Ivan Pećin; Ana Vrdoljak; Sandra Karanović; Mirjana Fuček; Tamara Božina; Jelena Kos; Tajana Željković Vrkić; Vedran Premužić; Marijana Živko; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Both higher fitness level and higher current physical activity level may be required for intramyocellular lipid accumulation in non-athlete men.

Authors:  Nozomu Yamasaki; Yoshifumi Tamura; Kageumi Takeno; Saori Kakehi; Yuki Someya; Takashi Funayama; Yasuhiko Furukawa; Hideyoshi Kaga; Ruriko Suzuki; Daisuke Sugimoto; Satoshi Kadowaki; Motonori Sato; Takashi Nakagata; Miho Nishitani-Yokoyama; Kazunori Shimada; Hiroyuki Daida; Shigeki Aoki; Hiroaki Satoh; Ryuzo Kawamori; Hirotaka Watada
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.